BioSpace News Archive

Tocagen Inc. reported financial results and business highlights for the first quarter ended March 31, 2019.

DaVita Inc. announced results for the quarter ended March 31, 2019.

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) will present at the Bank of America Merrill Lynch Health Care Conference 2019 at 10:00 a.m. PT (1:00 p.m. ET) on Tuesday, May 14, 2019, in Las Vegas. Kevin Gorman, Chief Executive Officer, and Matt Abernethy, Chief Financial Officer, of Neurocrine Biosciences will present at the conference.

Rigel Pharmaceuticals, Inc. reported financial results for the first quarter ended March 31, 2019, including sales of TAVALISSE®, for the treatment of thrombocytopenia in adults with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment.

Evolent Health, Inc. announced financial results for the quarter ended March 31, 2019.

Regulus Therapeutics Inc. announced the closing of the first tranche of its previously announced private placement of equity.

Phase 1 results including biomarker data in asthmatics for lung-selective inhaled pan-JAK inhibitor TD-8236 expected in third quarter 2019

On track to deliver more than 500,000 test samples and more than $220 million in revenue in 2019

Genomic Health, Inc. reported financial results and business progress for the quarter ended March 31, 2019.

Lantheus Holdings, Inc. announced that Mary Anne Heino, President and Chief Executive Officer, and Robert Marshall, Chief Financial Officer, will present at the 2019 UBS Global Healthcare Conference at 1:00 p.m. ET on Tuesday, May 21 at the Grand Hyatt New York.